Dr. Bipin Gupta, PhD | Founder, CEO & CSO
Dr. Gupta founded DBS in 1994. He completed his post-doctoral studies at Stanford Medical School and worked as a scientist in the field of IHC. Dr. Gupta has numerous publications in the area of IHC.
Gerald Weiss M.D.,F.C.A.P | Consulting Pathologist
Dr. Weiss is a Board Certified Pathologist (Anatomic and Clinical Pathology) with a special interest in immunohistochemistry. He has founded and directed a number of CLIA Laboratories. He is currently Director of Laboratories at Regional Medical Center of San Jose and Bioreference Laboratories in Campbell California. He serves on the Board of Directors of the California Society of Pathologists.
Marc Key, PhD | Chief Scientific Advisor
Marc Key, has over 25 years of experience in research and product development. Dr. Key has held senior positions with companies such as Dako and BioGenex Corporation. He has been responsible for R & D teams launching hundreds of products into the pathology market and holds some of the most significant patents in the field of Immunohistochemistry testing. Dr. Key holds a BS from Iowa State University, an MS from the University of Montana and a PhD from the Medical University of South Carolina.
Pathanjaly Hariharan | Head of Global Sales and Marketing
Pathanjaly Hariharan (Hari) joined the growing DBS team in 2017 to strengthen its executive management. Pathanjaly comes with over 20 years of sales experience in clinical diagnostics with extensive knowledge of the IHC market within the United States and internationally. Prior to joining DBS, he was the International Sales Manager for Biocare Medical and was responsible for launching and expanding the international market.